Cordyceps Dosage & Consumption
Published doses range from about 1 g/day (cordycepin-standardized beverage) to 3 g/day (Cs-4 capsules), and whether a product is fruiting body or fermented mycelium determines whether you can verify it against those doses at all; Cordyceps can also meaningfully interact with blood thinners and diabetes medication.
Doses used in published research
A 12-week trial in 15 healthy older adults (age 50-75) used 999 mg/day of the Cs-4 fermentation product (333 mg capsules, three times daily), per Chen et al., 2010, Journal of Alternative and Complementary Medicine, and found significant improvement in submaximal exercise thresholds but not VO2max. A separate 5-week trial in 22 endurance-trained male cyclists used the same product at 3 g/day, per Parcell et al., 2004, International Journal of Sport Nutrition and Exercise Metabolism, and found no performance benefit. A third, more recent trial tested a much lower, purified-cordycepin dose (2.85 mg/day in a beverage) over 8 weeks in 40 healthy adults and found significant immune-marker changes.
| Study | Population | Dose | Duration |
|---|---|---|---|
| Chen et al., 2010, J. Altern. Complement. Med. | Healthy adults 50-75 (n=15 completed) | 999 mg/day Cs-4 fermentation product (333 mg x3) | 12 weeks |
| Parcell et al., 2004, Int. J. Sport Nutr. Exerc. Metab. | Endurance-trained male cyclists (n=22) | 3 g/day CordyMax Cs-4 | 5 weeks |
| Immune-marker trial (2024) | Healthy adults 18-55, Thailand (n=40 completed) | 75 mL beverage containing 2.85 mg cordycepin/day | 8 weeks |
Fruiting body, fermented mycelium, or raw powder: what each form delivers
Unlike Reishi, where the split is about extraction method, Cordyceps' key label question is source material: is it a cultivated C. militaris fruiting body, or a fermented mycelial strain grown to stand in for wild C. sinensis? The two aren't interchangeable on paper, even though both have clinical evidence behind them.
| Form | What it delivers | Worth knowing |
|---|---|---|
| Fruiting body extract (capsule or powder) | Cordycepin and, if hot-water extracted, beta-glucans. Only source type where a brand can publish an actual cordycepin percentage, since C. militaris fruiting bodies contain the compound directly. | Check the label for a named species (C. militaris) and a published cordycepin or beta-glucan figure; this is the only form that lets you compare against the research doses above. |
| Mycelial fermentation biomass (capsule or powder) | Variable, strain- and process-dependent polysaccharides and other compounds; this is what Cs-4, the exact material in both exercise trials above, actually is. | Effective in the studied clinical dose (999 mg-3 g/day of that specific strain), but most consumer mycelium products don't disclose which strain they use or publish a cordycepin figure, so you can't verify the product matches the tested material. |
| Raw dried powder, no extraction | Whatever compounds survive drying and grinding, at low concentration relative to an extract. | The least concentrated and least studied form; none of the clinical trials on this page used raw powder. |
Reported side effects
Per the NCBI Bookshelf LiverTox entry, Cordyceps extracts are generally well tolerated, with adverse effects across clinical trials described as uncommon and minimal (mostly GI discomfort, dry mouth, poor appetite, and rash). Only one isolated case report exists in the literature: an 81-year-old woman who developed hepatoportal sclerosis after 5 years of use, which improved after she stopped. Multiple trials monitoring liver enzymes found no changes attributable to Cordyceps.
Drug interactions worth knowing
Per Memorial Sloan Kettering Cancer Center's clinical summary, Cordyceps may inhibit platelet aggregation, and a documented case links daily Cordyceps use to excessive bleeding following a tooth extraction. It also has an additive blood-sugar-lowering effect with insulin and other antidiabetic medications. People with myelogenous cancers should avoid Cordyceps due to its stimulation of red blood cell progenitor proliferation, and transplant recipients on immunosuppressants like cyclosporine should consult their provider first, since Cordyceps stimulates immune activity through T-helper and NK cells.
This page doesn't evaluate how any specific supplement product's label dose compares to these study doses; see the Cordyceps hub for named-brand source-material comparisons, or the individual brand reviews linked from that page.
Frequently Asked Questions
Sources
- Chen et al., 2010, Journal of Alternative and Complementary Medicine: Double-blind, placebo-controlled trial: Cs-4 999 mg/day for 12 weeks in healthy adults 50-75 (n=15 completed); metabolic threshold +10.5% (p=0.022), ventilatory threshold +8.5% (p=0.031)
- Parcell et al., 2004, International Journal of Sport Nutrition and Exercise Metabolism: Randomized, double-blind trial: CordyMax Cs-4 3 g/day for 5 weeks in 22 endurance-trained male cyclists; no significant change in VO2peak or time-trial performance
- Immune-marker trial, 2024: Randomized controlled trial: 2.85 mg cordycepin/day for 8 weeks in healthy adults (n=40 completed); significant NK cell activity and inflammatory marker changes
- NCBI Bookshelf, LiverTox: Cordyceps: Clinical safety review; likelihood category E, mild adverse events, one isolated case report
- Memorial Sloan Kettering Cancer Center, Cordyceps clinical summary: Reported bleeding case, antiplatelet/antidiabetic drug interactions, myelogenous cancer and immunosuppressant warnings